Dogwood Therapeutics DWTX Business Segments — General And Administrative Expense

Similar metrics at other companies

URGSingle Reportable — General And Administrative Expense

$3.92M+80.5%

ACLSSingle Reportable — General And Administrative Expense

$26.76M+54.2%

CBRLSingle Reportable — General And Administrative Expense

$49.39M+7.3%

RSSSSingle Reportable — General And Administrative Expense

$1.63M-11.9%

IOVASingle Reportable — General And Administrative Expense

$18.7M-5.8%

VERXSingle Reportable — General And Administrative Expense

$54.34M+20.7%

Questions, answered.

What is Dogwood Therapeutics's business segments — general and administrative expense?

Dogwood Therapeutics (DWTX) reported business segments — general and administrative expense of $2.41M in Q1 2026.

How has Dogwood Therapeutics's business segments — general and administrative expense changed year-over-year?

Dogwood Therapeutics's business segments — general and administrative expense increased by 20.8% year-over-year, from $1.99M to $2.41M.

What is the long-term trend for Dogwood Therapeutics's business segments — general and administrative expense?

Over 2 years (2023 to 2025), Dogwood Therapeutics's business segments — general and administrative expense has grown at a 28.1% compound annual growth rate (CAGR), from $3.72M to $6.1M.

What does business segments — general and administrative expense mean?

Represents the overhead costs associated with the day-to-day management and operation of the business, including executive salaries, legal, accounting, and office expenses. Monitoring this helps assess the company's operational discipline and administrative efficiency.